Invited Speakers: see program
Program:
PROGRAM OF MORNING SESSIONS
Sunday, September 22
- P. Kleihues (Lyon, France): Overview of the course: the causes of human cancer.
METHODOLOGY FOR IDENTIFICATION OF CANCER GENES (I)
- G. Romeo (Lyon, France): Genetic polymorphisms for the study of mendelian and non-mendelian inheritance.
- M. Stratton (Sutton, UK): The genetics of breast cancer.
- D. Goldgar (Lyon, France): Epidemiology of familial vs sporadic tumours.
- F. Mitelman (Lund, Sweden): Cancer Cytogenetics.
Monday, September 23
TESTING FOR GENETIC PREDISPOSITION TO CANCER: SCIENTIFIC, ETHICAL AND SOCIAL ISSUES
- J.J. Cassiman (Leuven Belgium): to be established
- S. Ayme (Paris, France): to be established
- R. Eeles (Sutton, UK): to be established
- G. Geller (Baltimore, MD, USA): to be established
- T. Marteau (London, UK): to be established
- H. Sobol (Marseille, France): to be established
Tuesday, September 24
ONCOGENES AND TUMOUR SUPPRESSOR GENES
- G. Draetta (Milan, Italy): Cell cycle regulatory proteins in oncogenesis.
- M. Negrini (Philadelphia, PA, USA): Approaches to cloning of tumour suppressor genes.
- C. Croce (Philadelphia, PA, USA): Oncogenic conversion in hematological disorders.
- W. van de Ven (Leuven, Belgium): Approaches to cloning of translocations.
- P. Radice (Milan, Italy): Cytogenetics and molecular genetics of thyroid tumours.
Wednesday, September 25
DNA REPAIR DEFECTS AND SUSCEPTIBILITY TO CANCER DEVELOPMENT
- M. Radman (Paris, France): Mismatch repair and genetic stability from bacteria to humans.
- G. Weeda (Rotterdam, Netherlands): Review of XP, Fanconi, AT, etc.
- Z.Q. Wang (Vienna, Austria): The role of Poly (ADP-ribosyl) transferase (ADPRT/PARP) in genomic stability.
- P. Di Fiore (Milan, Italy): to be established
Thursday, September 26
MODEL SYSTEMS
- G. Thomas (Paris, France): Neurofibromatosis type 2, a model disease for the study of tumor suppression.
- R. Fodde (Leiden, Netherlands): Genotype-phenotype correlations in colorectal cancer: the lesons from the mouse models.
- R. Montesano (Lyon, France): Genetic alterations in oesophageal cancer. Relevance to etiology and pathogenesis.
- E. van Meir (Lausanne, Switzerland): Tumour progression in human astrocytoma.
Friday, September 27
TUMOURS AND IMPRINTING
- C. Sapienza (Philadelphia, PA, USA): Cancer genetics and genome imprinting.
- D. Barlow (Amsterdam, Netherlands): Approaches to cloning of tumour suppressor genes.
- C. Junien (Paris, France): to be established
- P. Devilee (Leiden, Netherlands): Mechanisms of genomic imprinting.
- M. Schwab (Heidelberg, Germany): Genetic instability in human neuroblastoma.
One afternoon (to be established):
MOLECULAR DIAGNOSTIC AND COUNSELLING FOR FAMILIES WITH CANCER SYNDROMES
- M. Pierotti (Milan, Italy)
- G. Lenoir (Lyon, France)
- B. Pasini (Milan, Italy)
- D. Stoppa-Lyonnet (Paris, France)
- P. Hainaut (Lyon, France)
Each afternoon: 2 rounds of workshops (1-2 Faculties with 15-20 students).
Saturday, September 28
EXCURSION THROUGH THE CINQUE TERRE
Registration :
- Purpose:
The course will be addressed to:
(a) PhD students and post-doctoral fellows engaged in research on cancer;
(b) MD and PhD who are involved in the delivery of services of patients and families with heritable cancer;
(c) geneticists and other medical specialists who need to attend an introductory course on cancer genetics;
(d) a limited number of genetic associates or genetic nurses who have a scientific background and are already working in oncology or genetics departments.
The course should create a bridge between the basic knowledge which is accumulating in the field of cancer genetics and its medical applications.
- Format:
Review lectures given during morning sessions on different aspects of cancer genetics; two sessions of 6-7 concurrent workshops each afternoon: one or more faculty members will discuss with a small group of students different aspects of research in cancer genetics and/or practical applications oriented towards the delivery of services (e.g. genetic counselling).
- Fees:
It. Lire 600,000, to cover tuition fee, course fee, course book, lunches, coffee breaks, welcome party, excursion, certificate of attendance.
- Accommodation:
Half board per day per person: Lire 77.000 - 107.000, depending on the type of room.
- Venue:
Grand Hotel dei Castelli, Sestri Levante (a seaside resort, 40 km from Genoa).
- Language: English
- Applications:
The course will be limited to 120 participants. Send by regular mail a short c.v., a letter of recommendation from an established scientist or clinician, a brief description of your scientific interests (please underline about 10 key words), and a certificate documenting your fluency in English to:
Ms Silvia Trucco
Laboratory of Molecular Genetics
Istituto G. Gaslini
16148 Genoa, Italy
Tel.: +(39) 10 5636.400/370
Fax: + (39) 10 377 97 97
E-mail: genetica@igecuniv.cisi.unige.it
A selection committee will screen the applications starting from May 1st, 1996.
Applications will be accepted until the course is full. Notifications of acceptance will be sent in July 1996.
- Fellowships:
A limited number of fellowships covering registration fees and, in special cases, partial support for local accommodation will be provided. Candidates admitted to the course will be encouraged to apply for financial support directly to their own national cancer charities.
Deadline for Abstracts: -
Email for Requests and Registration: Genetica@IGECUNIV.CISI.UNIGE.IT